Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologic or cytologic confirmation of select incurable solid malignancies that are advanced (metastatic and/or unresectable), with measurable disease per RECIST v1.1
Available tumor tissue for biomarker analysis
Eastern Cooperative Oncology Group Performance Status (ECOG) status of 0 or 1
You may not be if
Known or suspected central nervous system (CNS) metastases or with the CNS as the only site of active disease
History of interstitial lung disease / pneumonitis
Prior malignancy active within the previous 2 years except for locally curable cancers that have been cured, such as basal or squamous cell skin cancer
Encephalitis, meningitis, or uncontrolled seizures in the year prior to informed consent
Clareo Health | An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
